The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies ...
Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that ...
After years of quiet maturation, new approach methodologies and emerging clinical success for cell therapies are fueling ...
Omeros Corporation (Nasdaq: OMER) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...
Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital ...
Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today the ...
(NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for ...
(Nasdaq: EXEL) announced today that its third quarter 2026 financial results will be released on Thursday, October 29, 2026, ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Stealth AXiS™ surgical system ...
New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch ...
Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and regenerative ...
Battelle Extends Longstanding CDC Partnership with New Public Health Data and Mission Support Awards
Battelle today announced two significant awards from the Centers for Disease Control and Prevention (CDC), reinforcing the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results